1) thrombin antithrombin III complex
凝血酶抗凝血酶Ⅲ复合物
2) thrombin/antithrombin complexes
凝血酶抗凝血酶复合物
1.
Objective To measure various coagulation markers such as prothrombin fragment F1+2(F1+2),thrombin/antithrombin complexes(TAT) and D-dimer,and evaluate the outcome of early diagnosis and management of pre-disseminated intravascular(coa)-gulations(pre-DIC) in high-risk neonates.
目的探讨监测危重新生儿血浆凝血酶原片段F1+2、凝血酶抗凝血酶复合物(TAT)及D-二聚体等凝血及纤溶因子水平对弥散性血管内凝血前期(pre-DIC)的诊断及治疗意义。
3) thrombin-antithrombin complex
凝血酶-抗凝血酶复合物
1.
Objective:To detect D-Dimer(DD),thrombin-antithrombin complex(TAT),plasmin-antiplasmin complex(PAP) in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) in order to find their clinical significance in the early diagnosis,treatment and prognosis of COPD.
目的:检测慢性阻塞性肺疾病(COPD)患者在急性加重期血浆D-二聚体(D-D)、凝血酶-抗凝血酶复合物(TAT)、纤溶酶-抗纤溶酶复合物(PAP)含量。
4) Thrombin-antithrombin complexes
凝血酶-抗凝血酶复合物*
5) Antithrombin Ⅲ
抗凝血酶Ⅲ
1.
Correlative study between the changes of antithrombin Ⅲ activity & D-dimer level and sequential organ failure assessment score in the patients with sepsis;
脓毒症患者血浆抗凝血酶Ⅲ及D-二聚体与SOFA评分的相关性研究
2.
Screening of Antithrombin Ⅲ(AT-Ⅲ) with High Bioactivity by DNA Shuffling in P.pastoris;
利用DNA改组筛选高活性抗凝血酶Ⅲ
3.
Expression of Soluble Recombinant Human Antithrombin Ⅲ(AT-Ⅲ) inP.pastoris;
人抗凝血酶Ⅲ(AT-Ⅲ)在毕赤酵母中可溶性表达
6) Antithrombin-Ⅲ
抗凝血酶Ⅲ
1.
Immunoresonance Scautering Spectral Assay for the Determination of Antithrombin-Ⅲ;
抗凝血酶Ⅲ的免疫共振散射光谱分析
2.
Antithrombin-Ⅲ concentrations in lung cancer patients were significantly lower(73.
目的对119例肺癌患者D二聚体(D-dimer)和抗凝血酶Ⅲ(antithrombinⅢ,AT-Ⅲ)活性进行检测,以探讨上述指标与肺癌的关系及意义。
补充资料：凝血酶原复合体减低症
凝血酶原复合体减低症
prothrombin complex deficiency
凝血酶原复合体(包括Ⅱ、Ⅶ、Ⅸ、Ⅹ因子）减低症，可分为先天性和获得性两种。先天性者极少见，为家族性，常染色体隐性遗传；获得性是由于维生素K的摄入、吸收或利用不足所致。出血症状和凝血时间虽可与血友病相似，但患者凝血酶原时间延长，除极少数先天缺乏外，患者维生素K治疗有效。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条